Discover our courses

Discover our courses

Instructional Courses are among the core educational pillars of our Congress.
This section will be progressively updated as the program of each Course is finalized.

Explore the planned topics, preview the content, and start building your personalized Congress agenda.

Discover our courses

Round Holes in Myopes: Evidence for Two Different Mechanisms

Richard Spaide (USA)

TBD

Giovanni Staurenghi (Italy)

Clinical Implications of Non-Exudative Fluid in Age-Related Macular Degeneration

Giuseppe Querques (Italy)

Adaptive Optics Flood-Illumination Reveals Junctional Microstructure Beyond Conventional Imaging in Geographic Atrophy due to Age-Related Macular Degeneration

Aude Ambresin (Switzerland)

Swept Source Ultra-Wide Field OCT Angiography for Choroidal Vascular Anatomy Analysis in Patients with Central Serous Chorioretinopathy

Joseph Z. Fang (Switzerland)

AMD Registry on Systemic Complement Inhibition and GA Progression

Talisa Forest (USA)

Proliferative diabetic retinopathy remains one of the most complex and unforgiving areas of vitreoretinal surgery. This course will focus on practical surgical decision-making in real-world PDR, from non-clearing vitreous haemorrhage to combined tractional and rhegmatogenous retinal detachment. Through expert case discussions and high-quality surgical video, the faculty will address the key questions faced in everyday practice: when to operate, how to optimize the eye preoperatively, how to approach membrane dissection safely, and how to manage complications and recurrence. Rather than revisiting standard concepts, this session will highlight modern strategies, technical pearls, and common pitfalls in complex PDR surgery. The aim is to provide attendees with actionable lessons that can improve confidence, safety, and outcomes in diabetic vitrectomy.

Optimising surgical planning in PDR: when anti-vegf helps, when it harms, and when imaging warns

Mario Romano (Italy)

When is it time to operate in PDR?

Rodrigo Anguita Henriquez (United Kingdom)

Membrane dissection in complex PDR: surgical tactics for safe traction release

Maria Berrocal (Puerto Rico)

Intraoperative trouble-shooting in diabetic vitrectomy

Aude Couturier (France)

Postoperative recurrence and long-term stability: how do we reduce failure?

Pallavi Tyagi (United Kingdom)

Final panel discussion - What would you do in this case? Rapid-fire 3 difficult PDR scenarios

Moderators: Marion R. Munk (Switzerland) and Quan Dong Nguyen (USA)

Latest challenges in implementing AI in retina: what we have learned from Vision Code 2026

Mario Romano (Italy)

Artificial Intelligence for geographic atrophy trial recruitment: an imaging-integrated prescreening pipeline

Niranjan Manoharan (USA)

Implementing the automated geographic atrophy area algorithm into clinical workflows

Roomasa Channa (USA)

Implementation experience, validation and clinical outcomes of autonomous AI-based retinopathy screening in pediatric populations

Rita Wolf (USA)

Comparative performance of AI-based models in evaluating Goldmann visual fields in inflammatory retinal diseases

Jia-Horung Hung (USA)

AI-based automated identification and quantitative analysis of hyperreflective vitreous particles on OCT volume scans in uveitis

Wataru Matsumiya (Japan)

Automated, point-of-care, triage of choroidal lesions on ultra-widefield imaging: a human-in-the-loop deep learning model for detecting high risk referrable melanoma

Yasir Sepah (USA)

Beyond the retina: toward foundation models for external-eye imaging in oculoplastics and oculomics

Georgie Nahass (USA)

Informed Consent for AI in an Epistemic Void

Mary K. Daly (USA)

The prevalence of myopia is rapidly growing and is an epidemic in many parts of the globe. Due to advances in imaging, there have been a number of novel insights in recent years regarding the pathophysiology and progression of this disorder. These insights provide avenues towards novel therapeutics which may improve the outlook and prognosis for patients with this disease. This course brings together a number of global experts on this topic to prevent the latest advances in our understanding of pathophysiology that have been informed my multimodal imaging.

Consensus nomenclature for describing myopic maculopathy

Richard F. Spaide (USA)

Organization of scleral fibers in myopic staphyloma

Kyoko Ohno-Matsui (Japan)

Biomechanical hypothesis for myopic macular schisis

Andrea Govetto (Italy)

Clinical relevance of perforating scleral vessels in myopic eyes

Srinivas Sadda (USA)

Lacquer Cracks and myopic macular neovascularization

Giuseppe Querques (Italy)

Myopic macular atrophy in the setting of macular neovascularization

Aude Couturier (France)

The process of medical decision-making in retinal laser and the best approach to an individual laser treatment strategy is important for achieving the best clinical outcomes. This course will discuss treatment strategies in retinal diseases with a focus on both common and special cases. Cases will include typical applications of retinal laser such as central serous chorioretinopathy, while also exploring emerging approaches for conditions such as intermediate AMD. After an introduction to the current role and standardization of retinal laser and its future potential, faculty presentations will cover current indications, outcomes, and new laser strategies in macular diseases, followed by a practical case-based session.

Introduction: current role and standardization of retina laser and its potential for future use

Lisa Toto (Italy)

SMART-PRP in practice: case-based insights from single-session vs multiple-session navigated PRP in PDR

Emad Abu Ishkedeim (Sweden)

Making focal laser work: practical guidance from planning to treatment

Dmitri Maltsev (Russia)

Targeted retinal ischemia laser treatment guided with widefield OCT-A imaging

Moatez Billah Mekki (Qatar)

Utilization of subthreshold laser in CSCR with SOLS parameter set in the presence of alternative treatment options

Francesca Amoroso (France)

The path towards a subthreshold laser treatment for iAMD

Jan Tode (Germany)

Practical session for participants showing laser treatment strategies

Jay Chhablani & Francesca Amoroso (USA & France)

Artificial intelligence (AI) is increasingly influencing the future of vitreoretinal surgery, from disease prediction and surgical planning to image analysis, intraoperative support, and automation. Despite this rapid progress, many ophthalmologists and researchers still lack practical training in AI and are uncertain how these technologies can be integrated into everyday vitreoretinal practice. This course is designed as a practical crash course for clinicians and researchers who want a clear and accessible introduction to AI in vitreoretinal surgery. It will cover the fundamentals of machine learning and neural networks, and then explore key clinical and surgical applications, including AI for proliferative diabetic retinopathy, predictive modelling, no-code algorithm development, and real-time computer vision in the operating theatre. It will also look ahead to the evolution from generative AI to agentic AI and its potential role in the development of surgical intelligence. Through clinically focused examples and practical discussion, the course will provide attendees with a structured overview of how AI can be applied in vitreoretinal surgery today, what its current limitations are, and where future opportunities are likely to emerge.

Machine learning and neural networks: a practical crash course

Philippe Valmaggia (Switzerland)

Building algorithms without coding: is no-code AI ready for clinicians?

Lorenzo Ferro Desideri (Switzerland)

Can AI improve the management and prevention of surgical proliferative diabetic retinopathy?

Aude Couturier (France)

Real-time computer vision in vitreoretinal surgery: improving intraoperative guidance

Stanislao Rizzo (Italy)

Predictive modelling in vitreoretinal surgery: diagnostic, improving risk assessment, surgical planning, and outcomes

Martin Zinkernagel (Switzerland)

From generative to agentic AI: the road to surgical intelligence

Rodrigo Anguita Henriquez (United Kingdom)

The aim of this course is to present a cutting edge update on imaging and therapeutic hot-topics in the retina space, as well as the application of AI and robotics in clinical practice. Different retinal diseases will be addressed, including the ROP.

Novel functional tests for retinal diseases

Maria Cristina Parravano (Italy)

Retina Clinical Trials: Promising Novel Therapeutics in Development

Charles C. Wykoff (USA)

Targeting the non-perfusion in retinal diseases

Sobha Sivaprasad (United Kingdom)

What’s new in CSC: Multinational collaborative studies

Jay Chhablani (USA)

Non neovascular AMD: Not only OCT

Stela Vujosevic (Italy)

A global update on ROP

Darius Mosfeghi (USA)

Practical use of generative AI for retina specialists

Daniel Ting (Singapore)

The last frontier: robotics and AI in eye surgery

JP Hubschman (USA)

Robotic platforms: from laboratory to operating room

Marc de Smet (Switzerland)

Building a new robotic system: a surgeon-inventor's journey

Khalid Al Sabti (Kuwait)

First-in-human robotic retina surgery: the LUCA experience

Fanny Nerinckx (Belgium)

Intraoperative OCT and Digital Guidance: Closing the Loop for Robotic Automation

Rodolfo Mastropasqua (Italy)

Machine learning in robotic eye surgery: smarter instruments, safer surgery

Aya Barzelay Wollman (USA)

Is robotic eye surgery ready? Barriers, drivers and the road to adoption

Steven Schwartz (USA)

Panel: "Is robotic eye surgery ready — and who will pay for it?"

The topic is retinal detachment with proliferative vitreoretinopathy. In this course we will describe the main risk factors, the genetic predisposition and the vitreoretinal surgery of PVR, with the need or not of scleral buckling, lensectomy associated to vitrectomy in PVR, the surgical steps, the dissection of the proliferative tissue using PFCL and different stainings to improve the identification and dissection of the membranes, the importance of ILM dissection to prevent macular PVR, how to manage pediatric PVR, how to dissect the posterior hyaloid in these patients. We will also discuss the indications and technique of relaxing retinotomy, the best endotamponade agents. Traumatic PVR will be extensively explained, and the use of a combined technique of viscodissection and PFCL to open closed funnels. We will also discuss the different methods to prevent recurrent PVR, including Metotrexate. Some clinical cases will be presented and the audience will know the opinion of all the instructors, which will explain how to manage them, which surgery to employ. We will present didactic talks with scheduled questions and answers managed by the course director, discussion among panelists and with the audience, clinical cases of proliferative vitreoretinopathy with panel discussion, and a final summary with the take home messages of each presentation. The main objective of this course is that in conclusion of the talks of the proposed instructors and the discussion that attendee will be able to understand the process of PVR, the new surgical techniques employed and the prognostic factors of success. We want an interactive course with participation of the audience.

Retinotomy in PVR: when and how

Marco Mura (Italy)

Surgical management of pediatric PVR

Ehab el Rayes (Egypt)

Treatment of hypotony after multiples surgeries

Thomas Wolfensberger (Switzerland)

Drug therapies in PVR

Stanislao Rizzo (Italy)

Evolving techniques in the management of PVR

Jose García Arumí (Spain)

Diabetic macular edema (DME) remains a leading cause of vision loss among working-age adults, yet its management continues to evolve rapidly with advances in imaging, pharmacotherapy, and personalized care. This instructional course provides a comprehensive, evidence-based overview of contemporary DME management in 2026, integrating pathophysiology with practical treatment strategies. Participants will review the role of vascular endothelial growth factor (VEGF), inflammation, and systemic factors in DME development, alongside the latest diagnostic approaches including OCT biomarkers and multimodal imaging. The course will emphasize individualized treatment paradigms, highlighting first-line anti-VEGF therapies, emerging longer-acting agents, and the expanding role of corticosteroid implants in selected patients. Through case-based discussions and practical algorithms, attendees will gain actionable insights into tailoring therapy, improving visual outcomes, and minimizing complications. By the end of the course, participants will be equipped with up-to-date knowledge and clinical tools to deliver personalized, efficient, and durable care for patients with DME in modern practice.

Pathophysiology

Tunde Peto (United Kingdom)

Diagnostic Workup & Imaging

Giuseppe Querques (Italy)

Anti-VEGF Therapy

Stela Vujosevic (Italy)

Corticosteroid & Laser Therapy

Marco Lupidi (Italy)

Practical Case Discussions & Questions

The choroid is a central anatomical structure, particularly important for the nourishment and metabolic support of the outer retina, including the photoreceptors and retinal pigment epithelium. Therefore, it is likely to play a significant role in the pathogenesis and progression of age-related macular degeneration (AMD). In recent years, advances in imaging technologies—especially enhanced depth imaging optical coherence tomography (EDI-OCT) and swept-source OCT—combined with artificial intelligence (AI)-based analysis have substantially improved our understanding of the choroid and its complex involvement in AMD. These developments allow for a more precise visualization and quantification of choroidal thickness, vascular structure, and biomarkers such as pachyvessels or choriocapillaris alterations. As a result, distinct choroidal patterns can now be associated with different AMD phenotypes, including Geographic Atrophy, pachychoroid spectrum diseases, and neovascular AMD. This course will focus on the interpretation of choroidal OCT findings and their relevance across various AMD subtypes. Particular emphasis will be placed on how these insights may refine our understanding of disease mechanisms and support more individualized treatment strategies, including anti-VEGF therapy and emerging therapeutic approaches.

Choroidal anatomy and structure in OCT

Richard Spaide (USA)

Choroidal changes in chorioretinal disorders

Mario Romano (Italy)

Choroidal Changes in polypoidal choroidal vasculopathy

Gemmy Cheung (Singapore)

Choroidal Changes in Geographic Atrophy

Enrico Borelli (Italy)

Choroidal changes during aging and in neovascular AMD

Daniel Pauleikhoff (Germany)

Visual function in AMD: the endpoints dilemma

Anat Loewenstein (Israel)

Exploring standard and low luminance visual acuity in AMD

Sobha Sivaprasaid (UK)

Contrast sensitivity in understanding AMD

Karl G. Csaky (USA)

Microperimetry for monitoring AMD

Elisabetta Pilotto (Italy)

Reading ability in AMD

Edoardo Midena (Italy)

This course provides a roadmap for shifting the AMD paradigm from reactive treatment to proactive prevention and early detection. Leading experts will dissect the evidence for novel strategies, including home-based monitoring, systemic and dietary interventions, AI-powered risk stratification, and functional testing. The session will equip clinicians with a practical framework to identify at-risk patients earlier and implement strategies to delay or prevent the transition to advanced AMD.

Setting the stage: a multi-faceted approach to AMD prevention

Roy Schwartz, Marion Munk (UK, Switzerland)

Evidence-based dietary & genetic prevention

Caroline Klaver (The Netherlands)

Detecting conversion early with home OCT

Anat Loewenstein (Israel)

Pinpointing dysfunction with microperimetry

Gregor Reiter (Austria)

Dark Adaptation as a biomarker for progression

Marion R. Munk (Switzerland)

AI-powered risk stratification from retinal images

Omer Trivitzki (Israel)

The systemic link: evaluating statins, metformin, and other drugs for AMD

Roy Schwartz (UK)

While AI tools for geographic atrophy are rapidly emerging, few clinicians know how to implement them in daily practice. This course provides a practical, patient-centered framework for integrating AI throughout the GA management pathway—from differential diagnosis to treatment monitoring. Through live demonstrations and real-world cases, experts will show clinicians which tools are available now, how to use them, and how they transform patient care and shared decision-making.

From hype to practice: AI as your GA co-pilot

Roy Schwartz, Caroline Baumal (UK, USA)

Step 1: getting the diagnosis right — AI for GA vs. genetic mimics

Dinah Zur (Israel)

Step 2: who needs close follow-up? AI-based risk stratification

Gregor Retier (Austria)

Step 3: measuring & monitoring — from baseline to treatment response

Aude Ambresin (Switzerland)

Step 4: beyond structure — AI for functional monitoring in GA

Caroline Baumal (USA)

Step 5: crystal ball—predicting individual patient trajectories

Roy Schwartz (UK)

The next frontier: future needs for AI in GA management

Omer Trivitzki (Israel)

Managing posterior uveitis, autoimmune retinopathies, and their sight-threatening complications requires a multifaceted approach, combining rapid diagnostics, targeted systemic therapies, and precise surgical interventions. This 60-minute instructional course provides a highly dynamic, comprehensive update on the medical and surgical management of complex intraocular inflammation. To maximize the breadth of knowledge shared, the session features a rapid-fire format, gathering nine esteemed international experts to deliver concise, high-yield insights. The course begins by exploring the latest advancements in diagnostic modalities and pathophysiology. Attendees will learn the support multimodal imaging and OCT angiography to monitor subclinical disease activity, identify the elusive clinical hallmarks of autoimmune retinopathies, and review the inflammatory biomarkers driving retinal vasculitis. Following this, the focus will shift to clinical assessment, emphasizing the critical steps required to distinguish infectious from non-infectious etiologies and addressing the unique, high-stakes challenges of managing posterior segment inflammation in the pediatric population. The middle segment of the course dives into modern therapeutic paradigms. Experts will present the latest evidence on systemic immunosuppression, the optimal timing for biologic agents, and emerging pharmacotherapies that are currently reshaping the landscape of intraocular inflammation management. Finally, the course addresses the unique surgical challenges inherent in the inflamed eye. Presenters will share technical pearls for navigating vitreoretinal surgery in uveitic patients, managing complications such as tractional retinal detachment and severe macular edema, and mitigating postoperative inflammatory rebound. Through strictly timed 6-minute presentations, this course ensures an engaging, fast-paced learning experience. Participants will leave equipped with practical, evidence-based medical and surgical algorithms to optimize visual outcomes for patients of all ages.

Introduction and Objectives

Luca Cimino (Italy)

Decoding Disease Activity: Multimodal Imaging and OCTA in Posterior Uveitis

Marion Munk (Switzerland)

Autoimmune Retinopathies: Multimodal Imaging and Diagnostic Hallmarks

Luca De Simone (Italy)

Pathogenesis and Biomarkers: Understanding the Drivers of Retinal Vasculitis

Ahmed Abu El-Asrar (Saudi Arabia)

The Great Mimickers: Distinguishing Infectious vs. Non-Infectious Posterior Uveitis

Massimo Accorinti (Italy)

Small Eyes, High Stakes: Vision-Saving Strategies in Pediatric Posterior Uveitis

Elena Bolletta (Italy)

Uveitis as a Window to the Brain: Early Detection of Multiple Sclerosis

Abdulrahman Faisal H. Albloushi (Saudi Arabia)

Systemic Immunosuppression and Biologics: Tailoring Therapy to the Patient

Elisabetta Miserocchi (Italy)

Emerging Pharmacotherapies and Novel Clinical Trial Horizons in Uveitis

Quan Dong Nguyen (USA)

The Uveitic Vitrectomy: Indications, Timing, and Surgical Techniques

Marc De Smet (Switzerland)

Surgical Management of Retinal Complications in Uveitis

Sarah Touhami (France)

Central serous chorioretinopathy (CSCR) is a multifaceted retinal disorder with evolving understanding of its pathophysiology and management approaches. Recent advances in artificial intelligence-enhanced imaging, novel biomarker identification, and innovative therapeutic strategies are reshaping our comprehension of this condition. This symposium explores current and alternative concepts that challenge traditional paradigms in CSCR. Topics include AI-enhanced algorithms, outer retinal morphological patterns, the role of ocular perfusion pressure, scleral and corneal imaging, and emerging treatment modalities. These insights offer practical implications for clinical decision-making, risk stratification, and therapeutic intervention in routine practice.

Outer Retinal Erosion and Outer Retinal Pinching at the Origin of Subretinal Fluid in Central Serous Chorioretinopathy

Paolo Forte (Italy)

Automatic Analysis of the Outer Segments in Central Serous Chorioretinopathy

Sarah Mrejen (France)

The Role of the Choroidal Nervous System in Central Serous Chorioretinopathy

Francine Behar-Cohen (France)

Updates on the Hemodynamic Factor in Central Serous Chorioretinopathy

Marco Lupidi (Italy)

Intervortex Anastomosis: The Role of the Venous System in CSCR

Sibel Demirel (Turkey)

Results from the MICRoN Cohort

Jay Chhablani (USA)

Effect of Photodynamic Therapy on Choroidal Vascular Hyperpermeability in Central Serous Chorioretinopathy

Elodie Bousquet (USA)

Mainstays in CSCR Treatment

Chiara Maria Eandi (Italy)

This course provides general insides into ophthalmic oncology by short didactic cases presented by an expert panel. The audience can test and apply their knowledge.

Panel and Speakers

Cinzia Mazzini (Italy)

Doris Hadjistillanou (Italy)

Jens Kiilgaard (Denmark)

Emine Kilic (Netherlands)

Antonia Joussen (Germany)

Showcase of complex vitreoretinal surgeries, surgical decisions, and complication management from top experts globally.

Panel of experts

Remzi Avci (Turkey)

Siegfried Priglinger (Germany)

Claus Eckardt (Germany)

Jose García-Arumí (Spain)

Robert Maclaren (United Kingdom)

Francesco Boscia (Italy)

Yusuke Oshima (Japan)

Peter Szurman (Germany)

Grazia Pertile (Italy)

Christopher Riemann (USA)

Mario Romano (Italy)

The course will cover how to perform a suprachoroidal buckle as a minimal invasive approach to treat retinal Detachment, and show the steps to create a safe buckle, it will also discuss the materials and devices used. How to avoid difficulties and Video guide step by step will be used. The use of the technique in different case scenario will be discussed including use as a seldom approach, vitrectomy with SCB support for breaks, as well as minimal invasive office approach.

Faculty

Ehab El Rayes (Egypt)

Stratos Gotzaridis (Greece)

Peter Szurman (Germany)

Shohista Saidkasimova (United Kingdom)

The subject of this course is the progression of intermediate AMD to advanced AMD. This is a hot topic in the retinal community. Indeed, thanks to the introduction in the clinical practice of new high-resolution imaging tools, several predictors and biomarkers were recently reported. It would be of great relevance to be able to identify high-risk iAMD patients to change the follow-up of the patients and start treatment as soon as possible. Furthermore, new clinical trials are investigating new treatments for intermediate AMD that could reduce the probability of iAMD progression to advanced AMD (i.e. neovascular AMD or geographic atrophy).

Biomarkers of Progression to nAMD vs GA

SriniVas Sadda (USA)

High-Risk Lesions for Exudative AMD

Marta Fantuzzi (Italy)

Non-Exudative Fluid in Age-Related Macular Degeneration: Imaging, Pathophysiology, and Clinical Implications

Aliénor Vienne-Jumeau (Italy)

Phenotypic Characterization of GA Predictors of Development and Progression

Serena Fragiotta (Italy)

Advances In Photoreceptor And Retinal Pigment Epithelium Quantifications In Intermediate AMD

Ursula Schmidt-Erfurth (Austria)

Subthreshold Navigated Laser Treatment for Intermediate Age-Related Macular Degeneration

Tommaso Verdina (Italy)

New Treatments in iAMD: State-of-the-Art

Sandrine Zweifel (Switzerland)

This course explores the continuum from advanced retinal imaging to vision rehabilitation in patients with macular diseases. Through expert presentations, attendees will learn about diagnostic imaging biomarkers, the role of microperimetry in structural-functional assessment, current vision rehabilitation techniques, innovative low-vision technologies such as smart glasses, and recent developments in the understanding of Charles Bonnet Syndrome. The course aims to provide a comprehensive overview of diagnostic and rehabilitative strategies to improve patient care and quality of life.

Diagnostic Imaging Biomarkers in Macular Diseases

Mariacristina Parravano (Italy)

Microperimetry: Structural-Functional Assessment

Filippo Amore (Italy)

Vision Rehabilitation Techniques

Valeria Silvestri (Italy)

Smart Glasses and Their Use in Low Vision

TBD

Seeing More When Seeing Less: Latest Updates on Charles Bonnet Syndrome

Jasleen Jolly (Australia)

Instructors

Kunihiko Akiyama (Japan)

Francesco Pelligrini (Italy)

Danilo Ianetta (Italy)

Emmanuel Mavrikakis (Greece)

Alvaro Vega-Fernandez (Spain)

Giorgio Bravetti (Canada)

Salvatore Parrulli (Italy)

Mahmood Alrabiah (Kuwait)

Agenda

Introduction: Why Learn Pneumatic Retinopexy: Rajeev Muni

Pneumatic Retinopexy Case Selection: Francesco Pelligrini

Pneumatic Retinopexy Surgical Technique: Rajeev Muni

Pneumatic Retinopexy Complications: Kunihiko Akiyama

Pneumatic Retinopexy Experience in Italy: Danilo Ianetta

Pneumatic Retinopexy Experience in Japan: Kunihiko Akiyama

Pneumatic Retinopexy Cases From Simple to Complex: All Instructors Rapid Fire Cases

Pathophysiology of Retinal Displacement Following RRD Repair

Rajeev Muni (Canada)

Marginal Outer Retina Ridge Following RRD Repair: A Novel Imaging Finding with Significant Implications

Koby Brosh (Israel)

Fluid-Fluid Exchange/External Drainage and Implications for Displacement

Luis Escaf (Colombia)

FAF Shows Only the Tip of the Iceberg: Assessment of Retinal Displacement with Homography

Koby Brosh (Israel)

Stages of Retinal Reattachment

Aditya Bansal (USA)

Regulated vs Dysregulated RRD

Aurora Pecaku (Canada)

Pathophysiology of Outer Retinal Corrugations and Outer Retinal Folds

Rajeev Muni (Canada)

Morphological Stages of RRD

Aurora Pecaku (Canada)

Pathophysiology of Macular Hole in RRD: The Secret Lies in the Bacillary Layer

Aditya Bansal (USA)

Assessment and Implications of Residual Subretinal Fluid in RRD Repair

Shiva Sabour (Canada)

Is There an Open Break or Not: Outer Retinal Corrugations Provides the Answer

Jeffrey Mah (Canada)

The Implications of Vitreous Cortical Remnants in PVR

Roberto dell’Omo (Italy)

A Novel Conceptual Framework and Staging System for PVR

Rajeev Muni (Canada)

Traction must be Eliminated in RRD Repair: Fact or Fiction

Miguel Cruz Pimentel (USA)

Next Generation Techniques in RRD Repair

Rajeev Muni (Canada)

Introduction: Why Suprachoroidal Viscoepxy?

Anatomy/Physiology of the Suprachoroidal Space in RRD

Katherine Jung (Canada)

Suprachoroidal Viscopexy (SCVEXY) Guarded Needle Technique

Rajeev Muni (Canada)

SCXEXY: The Initial Experience

Rajeev Muni (Canada)

Suprachoroidal Viscoepxy Extended Indication Cases and Rescue Procedures

Aurora Pecaku (Canada)

PPV/SCVEXY for RRD

Aurora Pecaku (Canada)

A Novel Platform for SCVEXY

Rajeev Muni (Canada)

First in Human Cases: Initial Learning Curve

Luis Escaf (Colombia), Pablo Chamartin (Spain)

Use of Drainage and Gas/Air with SCVEXY

Luis Escaf (Colombia)

SCVEXY: Insights from Imaging

Shiva Sabour (Canada)

SCVEXY Long Term Safety/Potential Complications and their Management

Rajeev Muni (Canada)

This course will present selected surgical video clips to highlight the key steps of vitreoretinal procedures. The goal is to closely examine surgical techniques, instrument handling, and decision-making during surgery, allowing participants to better understand both the technical details and the overall surgical strategy. The near-live format enables the faculty to pause, review, and discuss critical moments that are often difficult to appreciate during live surgery. A panel of experienced vitreoretinal surgeons will analyze each case, share practical tips, discuss alternative approaches, and explore how they would manage challenging situations. The session is designed to promote interactive learning, open discussion, and the exchange of ideas, helping participants refine both their surgical skills and clinical judgment.

Moderators

Grazia Pertile (Italy)

Stratos Gotzaridis (Greece)

Video Presenters

Kazuaki Kadonosono (Japan)

Sengul Ozdek (Turkey)

Andrè Maia (Brazil)

Nina Berrocal (USA)

Marta Figueroa (Spain)

Lyndon Da Cruz (United Kingdom)

Maria Berrocal (Puerto Rico)

Stratos Gotzaridis (Greece)

Grazia Pertile (Italy)